Management of open-angle glaucoma after the LIGHT trial: what is the role of hospital optometri...

26 November 2019
Volume 20, Issue 4

This article outlines the laser treatment modalities for glaucoma and ocular hypertension.

Glaucoma, including primary open-angle glaucoma, is a leading cause of visual loss in the UK and around the world. Considered in the context of the optometrist’s role in glaucoma care, this article outlines the laser techniques used to treat the condition, together with the results of a new treatment study, the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

In each issue, Acuity poses a topical question on a tricky scenario to a panel of members.

Patients will be paid £25 per session and all travel expenses will be reimbursed.

Pressure on optometrists to treat glaucoma is likely to grow as case numbers are predicted to rise 44% by 2035. Beta blockers will remain a part of the fight ahead, as Adrian O’Dowd reports.